Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-540,000
Closed -$1.33M 22
2025
Q1
$1.33M Buy
+540,000
New +$1.28M 0.96% 14

Other funds holding SLRN

TowerView LLC's SLRN Position: Q2 2025 in Review

TowerView LLC sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 540,000 shares — an estimated $1.33M sold.

TowerView LLC first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $1.33M in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • TowerView LLC reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • TowerView LLC sold 540,000 ACELYRIN shares in Q2 2025, an estimated $1.33M.
  • TowerView LLC first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
  • TowerView LLC's ACELYRIN position peaked at $1.33M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on TowerView LLC's 13F filing for Q2 2025, filed 6 Aug 2025.